A dynamic transmission model with age-dependent infectiousness and reactivation for cytomegalovirus in the United States: Potential impact of vaccination strategies on congenital infection

References

• Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007; 17:253-76; PMID:17579921; http://dx.doi.org/10.1002/rmv.535
   PubMed Web of Science ®Google Scholar
• Colugnati FA, Staras SA, Dollard SC, Cannon MJ. Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infect Dis 2007; 7:71; PMID:17605813; http://dx.doi.org/10.1186/1471-2334-7-71
   PubMed Web of Science ®Google Scholar
• Adler SP, Nigro G. Clinical cytomegalovirus research: Congenital Infection. Cytomegaloviruses: From Molecular Pathogenesis to Intervention. London: Caister Academic Press; 2013. p. 60-61. Reddehase MJ, Lemmermann N, editors. vol 2.
   Google Scholar
• Malm G, Engman ML. Congenital cytomegalovirus infections. Semin Fetal Neonatal Med 2007; 12:154-9; PMID:17337260; http://dx.doi.org/10.1016/j.siny.2007.01.012
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Cytomegalovirus (CMV) and Congenital CMV Infection (http://www.cdc.gov/cmv/clinical/features.html). Accessed 26 July 2013.
   Google Scholar
• Engman ML, Malm G, Engstrom L, Petersson K, Karltorp E, Tear Fahnehjelm K, Uhlen I, Guthenberg C, Lewensohn-Fuchs I. Congenital CMV infection: prevalence in newborns and the impact on hearing deficit. Scand J Infect Dis 2008; 40:935-42; PMID:18720260; http://dx.doi.org/10.1080/00365540802308431
   PubMed Web of Science ®Google Scholar
• Hyde TB, Schmid DS, Cannon MJ. Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV. Rev Med Virol 2010; 20:311-26; PMID:20645278; http://dx.doi.org/10.1002/rmv.659
   PubMed Web of Science ®Google Scholar
• de Vries JJ, van Zwet EW, Dekker FW, Kroes AC, Verkerk PH, Vossen AC. The apparent paradox of maternal seropositivity as a risk factor for congenital cytomegalovirus infection: a population-based prediction model. Rev Med Virol 2013; 23:241-9; PMID:23559569; http://dx.doi.org/10.1002/rmv.1744
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Congenital CMV Infection Trends and Statistics (http://www.cdc.gov/cmv/trends-stats.html). Accessed 26 July 2013.
   Google Scholar
• Bate SL, Dollard SC, Cannon MJ. Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988–2004. Clin Infect Dis 2010; 50:1439-47; PMID:20426575; http://dx.doi.org/10.1086/652438
   PubMed Web of Science ®Google Scholar
• Cannon MJ. Congenital cytomegalovirus (CMV) epidemiology and awareness. J Clin Virol 2009; 46(Suppl 4):S6-10; PMID:19800841; http://dx.doi.org/10.1016/j.jcv.2009.09.002
   PubMed Web of Science ®Google Scholar
• Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev 2013; 26:86-102; PMID:23297260; http://dx.doi.org/10.1128/CMR.00062-12
   PubMed Web of Science ®Google Scholar
• Boppana SB, Pass RF, Britt WJ, Stagno S, Alford CA. Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J 1992; 11:93-9; PMID:1311066; http://dx.doi.org/10.1097/00006454-199202000-00007
   PubMed Web of Science ®Google Scholar
• Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 2007; 17:355-63; PMID:17542052; http://dx.doi.org/10.1002/rmv.544
   PubMed Web of Science ®Google Scholar
• Foulon I, Naessens A, Foulon W, Casteels A, Gordts F. A 10-year prospective study of sensorineural hearing loss in children with congenital cytomegalovirus infection. J Pediatr 2008; 153:84-8; PMID:18571542; http://dx.doi.org/10.1016/j.jpeds.2007.12.049
   PubMed Web of Science ®Google Scholar
• Dahle AJ, Fowler KB, Wright JD, Boppana SB, Britt WJ, Pass RF. Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J Am Acad Audiol 2000; 11:283-90; PMID:10821506
   PubMedGoogle Scholar
• Cannon MJ, Davis KF. Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health 2005; 5:70; PMID:15967030; http://dx.doi.org/10.1186/1471-2458-5-70
   PubMed Web of Science ®Google Scholar
• Pass RF, Zhang C, Evans A, Simpson T, Andrews W, Huang ML, Corey L, Hill J, Davis E, Flanigan C, et al. Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med 2009; 360:1191-9; PMID:19297572; http://dx.doi.org/10.1056/NEJMoa0804749
   PubMed Web of Science ®Google Scholar
• Krause PR, Bialek SR, Boppana SB, Griffiths PD, Laughlin CA, Ljungman P, Mocarski ES, Pass RF, Read JS, Schleiss MR, et al. Priorities for CMV vaccine development. Vaccine 2013; 32:4-10; PMID:24129123; http://dx.doi.org/10.1016/j.vaccine.2013.09.042
   PubMed Web of Science ®Google Scholar
• Dasari V, Smith C, Khanna R. Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases. Expert Rev Vaccines 2013; 12:661-76.
   PubMed Web of Science ®Google Scholar
• Griffiths P, Plotkin S, Mocarski E, Pass R, Schleiss M, Krause P, Bialek S. Desirability and feasibility of a vaccine against cytomegalovirus. Vaccine 2013; 31(Suppl 2):B197-203; PMID:23750795; PMID:23598482; http://dx.doi.org/10.1016/j.vaccine.2012.10.074
   PubMed Web of Science ®Google Scholar
• Azevedo RS, Amaku M. Modelling immunization strategies with cytomegalovirus vaccine candidates. Epidemiol Infect 2011; 139:1818-26; PMID:21396147; http://dx.doi.org/10.1017/S0950268811000343
   PubMed Web of Science ®Google Scholar
• Lanzieri T. Modelling the impact of vaccination on the epidemiology of CMV and congenital CMV infection in the United States. San Francisco: CMV meeting; 2012
   Google Scholar
• Lanzieri TM, Gambhir M, Ortega-Sanchez I, Bialek SR. Modeling the Impact of Vaccination on the Epidemiology of Cytomegalovirus (CMV) and Congenital CMV Infection in the United States - Preliminary Findings. The Fifteen Annual Conference on Vaccine Research; 2012; Baltimore.
   Google Scholar
• Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ. Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clin Infect Dis 2006; 43:1143-51; PMID:17029132; http://dx.doi.org/10.1086/508173
   PubMed Web of Science ®Google Scholar
• Mocarski E, Shenk T, Pass RF. Cytomegaloviruses. Fields Virology. Philadelphia: Lippincott, Williams & Wilkins; 2007. p. 2701-73. Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, editors.
   Google Scholar
• Arora N, Novak Z, Fowler KB, Boppana SB, Ross SA. Cytomegalovirus viruria and DNAemia in healthy seropositive Women. J Infect Dis 2010; 202:1800-3; PMID:21050121; http://dx.doi.org/10.1086/657412
   PubMed Web of Science ®Google Scholar
• Stowe RP, Kozlova EV, Yetman DL, Walling DM, Goodwin JS, Glaser R. Chronic herpesvirus reactivation occurs in aging. Exp Gerontol 2007; 42:563-70; PMID:17337145; http://dx.doi.org/10.1016/j.exger.2007.01.005
   PubMed Web of Science ®Google Scholar
• Brunner S, Herndler-Brandstetter D, Weinberger B, Grubeck-Loebenstein B. Persistent viral infections and immune aging. Ageing Res Rev 2011; 10:362-9; PMID:20727987; http://dx.doi.org/10.1016/j.arr.2010.08.003
   PubMed Web of Science ®Google Scholar
• Buchholz VR, Neuenhahn M, Busch DH. CD8+ T cell differentiation in the aging immune system: until the last clone standing. Curr Opin Immunol 2011; 23:549-54; PMID:21664807; http://dx.doi.org/10.1016/j.coi.2011.05.002
   PubMed Web of Science ®Google Scholar
• Almeida LN, Azevedo RS, Amaku M, Massad E. Cytomegalovirus seroepidemiology in an urban community of Sao Paulo, Brazil. Rev Saude Publica 2001; 35:124-9; PMID:11359197; http://dx.doi.org/10.1590/S0034-89102001000200004
   PubMed Web of Science ®Google Scholar
• United States Census Bureau (http://www.census.gov/#). Accessed 26 July 2013.
   Google Scholar
• Hens N, Aerts M, Faes C, Shkedy Z, Lejeune O, Van Damme P, Beutels P. Seventy-five years of estimating the force of infection from current status data. Epidemiol Infect 2010; 138:802-12; PMID:19765352; http://dx.doi.org/10.1017/S0950268809990781
   PubMed Web of Science ®Google Scholar
• Griffiths PD. Burden of disease associated with human cytomegalovirus and prospects for elimination by universal immunisation. Lancet Infect Dis 2012; 12:790-8; PMID:23017365; http://dx.doi.org/10.1016/S1473-3099(12)70197-4
   PubMed Web of Science ®Google Scholar
• Lanzieri T. Modelling CMV transmission & disease. The Development and Evaluation of Human Cytomegalovirus Vaccines Workshop 2012 Oct 1 (http://www.fda.gov/downloads/BiologicsBloodVaccines/NewsEvents/WorkshopsMeetingsConferences/UCM302082pdf 2012). Accessed 29 July 2013.
   Google Scholar
• GlaxoSmithKline Vaccine HPV-007 Study Group, Romanowski B, de Borba PC, Naud PS, Roteli-Martins CM, De Carvalho NS, Teixeira JC, Aoki F, Ramjattan B, Shier RM, et al. Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years. Lancet 2009; 374:1975-85; PMID:19962185; http://dx.doi.org/10.1016/S0140-6736(09)61567-1
   PubMed Web of Science ®Google Scholar
• Hekimoğlu M, Barlas M. Sensitivity analysis of system dynamics models by behavior pattern measures The 28th International Conference of the System Dynamics Society; 2010 July 25–29; Seoul, Korea. Conference Proceedings (http://www.systemdynamics.org/conferences/2010/proceed/papers/P1260.pdf). Accessed 27 February 2014.
   Google Scholar
• Sumner T, Shephard E, Bogle ID. A methodology for global-sensitivity analysis of time-dependent outputs in systems biology modelling. J R Soc Interface 2012; 9:2156-66; PMID:22491976; http://dx.doi.org/10.1098/rsif.2011.0891
   PubMed Web of Science ®Google Scholar
• Effelterre TV, Shkedy Z, Aerts M, Molenberghs G, Damme PV, Beutels P. Contact patterns and their implied basic reproductive numbers: an illustration for varicella-zoster virus. Epidemiol Infect 2009; 137:48-57; PMID:18466660; http://dx.doi.org/10.1017/S0950268808000563
   PubMed Web of Science ®Google Scholar
• The development and evaluation of human cytomegalovirus vaccines Workshop 2012 Oct 1 (http://www.fda.gov/downloads/BiologicsBloodVaccines/NewsEvents/WorkshopsMeetingsConferences/UCM302082.pdf). Accessed 29 July 2013.
   Google Scholar
• Adler SP, Marshall B. Cytomegalovirus infections. Pediatr Rev 2007; 28:92-100; PMID:17332168; http://dx.doi.org/10.1542/pir.28-3-92
   PubMed Web of Science ®Google Scholar
• Peckham CS, Johnson C, Ades A, Pearl K, Chin KS. Early acquisition of cytomegalovirus infection. Arch Dis Child 1987; 62:780-5; PMID:2821927; http://dx.doi.org/10.1136/adc.62.8.780
   PubMed Web of Science ®Google Scholar
• Tu W, Chen S, Sharp M, Dekker C, Manganello AM, Tongson EC, Maecker HT, Holmes TH, Wang Z, Kemble G, et al. Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children. J Immunol 2004; 172:3260-7; PMID:14978134; http://dx.doi.org/10.4049/jimmunol.172.5.3260
   PubMed Web of Science ®Google Scholar
• Zanghellini F, Boppana SB, Emery VC, Griffiths PD, Pass RF. Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. J Infect Dis 1999; 180:702-7; PMID:10438357; http://dx.doi.org/10.1086/314939
   PubMed Web of Science ®Google Scholar
• McVoy MA, Adler SP. Immunologic evidence for frequent age-related cytomegalovirus reactivation in seropositive immunocompetent individuals. J Infect Dis 1989; 160:1-10; PMID:2543705; http://dx.doi.org/10.1093/infdis/160.1.1
   PubMed Web of Science ®Google Scholar
• Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Tomba GS, Wallinga J, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 2008; 5:e74; PMID:18366252; http://dx.doi.org/10.1371/journal.pmed.0050074
   PubMed Web of Science ®Google Scholar
• Goeyvaerts N, Hens N, Ogunjimi B, Aerts M, Shkedy Z, Van Damme P, Beutels P. Estimating infectious disease parameters from data on social contacts and serological status. J R Stat Soc Ser C Appl Stat 2010; 59:255-77; http://dx.doi.org/10.1111/j.1467-9876.2009.00693.x
   Web of Science ®Google Scholar
• Wallinga J, Teunis P, Kretzschmar M. Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents. Am J Epidemiol 2006; 164:936-44; PMID:16968863; http://dx.doi.org/10.1093/aje/kwj317
   PubMed Web of Science ®Google Scholar
• Iannelli M, Martcheva M, Milner FA. Gender-Structured Population Modelling: Mathematical Methods, Numerics, and Simulation. SIAM Frontiers in Applied Mathematics; 2005.
   Google Scholar
• Yow MD, White NH, Taber LH, Frank AL, Gruber WC, May RA, Norton HJ. Acquisition of cytomegalovirus infection from birth to 10 years: a longitudinal serologic study. J Pediatr 1987; 110:37-42; PMID:3025394; http://dx.doi.org/10.1016/S0022-3476(87)80284-6
   PubMed Web of Science ®Google Scholar
• Ross SA, Arora N, Novak Z, Fowler KB, Britt WJ, Boppana SB. Cytomegalovirus reinfections in healthy seroimmune women. J Infect Dis 2010; 201:386-9; PMID:20039807; http://dx.doi.org/10.1086/649903
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (http://www.cdc.gov/nchs/index.htm). Accessed 26 July 2013.
   Google Scholar